SEOM clinical guidelines for anaplastic gliomas (2017)

被引：11

作者：

Balana, C. ^{[1
]}

Alonso, M. ^{[2
]}

Hernandez, A. ^{[3
]}

Perez-Segura, P. ^{[4
]}

Pineda, E. ^{[5
]}

Ramos, A. ^{[3
]}

Sanchez, A. R. ^{[6
]}

Teixidor, P. ^{[7
]}

Verger, E. ^{[5
]}

Benavides, M. ^{[8
]}

机构：

[1] Inst Catala Oncol Badalona, Ct Canyet S-N, Barcelona 08916, Spain

[2] Complejo Hosp Virgen del Rocio, Seville, Spain

[3] Hosp 12 Octubre, Madrid, Spain

[4] Hosp Univ Clin San Carlos, Madrid, Spain

[5] Hosp Clin Barcelona, Barcelona, Spain

[6] Complejo Asistencial Univ Leon, Leon, Spain

[7] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[8] Hosp Univ Reg & Virgen de la Victoria, Malaga, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2018年 / 20卷 / 01期

关键词：

Anaplastic glioma; Anaplastic astrocytoma; Anaplastic oligodendroglioma; HIGH-GRADE GLIOMAS; PHASE-III TRIAL; MALIGNANT GLIOMA; OLIGODENDROGLIOMA; CHEMOTHERAPY; RADIOTHERAPY; TEMOZOLOMIDE; OLIGOASTROCYTOMA; CLASSIFICATION; PROCARBAZINE;

D O I：

10.1007/s12094-017-1762-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.

引用

页码：16 / 21

页数：6

共 32 条

[1]

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas [J].

Albert, Nathalie L. ;

Weller, Michael ;

Suchorska, Bogdana ;

Galldiks, Norbert ;

Soffietti, Riccardo ;

Kim, Michelle M. ;

La Fougere, Christian ;

Pope, Whitney ;

Law, Ian ;

Arbizu, Javier ;

Chamberlain, Marc C. ;

Vogelbaum, Michael ;

Ellingson, Ben M. ;

Tonn, Joerg C. .

NEURO-ONCOLOGY, 2016, 18 (09) :1199-1208

[2]

Bent MJVD, 2016, J CLIN ONCOL S, V34, DOI 10.1200/JCO.2016.34.18_suppl.LBA2000

[3]

SEOM guideline for the treatment of malignant glioma [J].

Berrocal, Alfonso ;

Gil, Miguel ;

Gallego, Oscar ;

Balana, Carmen ;

Perez Segura, Pedro ;

Garcia-Mata, Jesus ;

Reynes, Gaspar .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (07) :545-550

[4]

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma [J].

Brada, Michael ;

Stenning, Sally ;

Gabe, Rhian ;

Thompson, Lindsay C. ;

Levy, David ;

Rampling, Roy ;

Erridge, Sara ;

Saran, Frank ;

Gattamaneni, Rao ;

Hopkins, Kirsten ;

Beall, Sarah ;

Collins, V. Peter ;

Lee, Siow-Ming .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4601-4608

[5]

CHEMOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIOMA [J].

CAIRNCROSS, G ;

MACDONALD, D ;

LUDWIN, S ;

LEE, D ;

CASCINO, T ;

BUCKNER, J ;

FULTON, D ;

DROPCHO, E ;

STEWART, D ;

SCHOLD, C ;

WAINMAN, N ;

EISENHAUER, E .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (10) :2013-2021

[6]

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].

Cairncross, Gregory ;

Wang, Meihua ;

Shaw, Edward ;

Jenkins, Robert ;

Brachman, David ;

Buckner, Jan ;

Fink, Karen ;

Souhami, Luis ;

Laperriere, Normand ;

Curran, Walter ;

Mehta, Minesh .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343

[7]

Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma [J].

Chamberlain, Marc C. ;

Johnston, Sandra .

JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) :359-367

[8]

Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Oligodendroglioma [J].

Chamberlain, Marc C. ;

Johnston, Sandra .

CANCER, 2009, 115 (08) :1734-1743

[9]

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 [J].

Chang, Susan ;

Zhang, Peixin ;

Cairncross, J. Gregory ;

Gilbert, Mark R. ;

Bahary, Jean-Paul ;

Dolinskas, Carol A. ;

Chakravarti, Arnab ;

Aldape, Kenneth D. ;

Bell, Erica H. ;

Schiff, David ;

Jaeckle, Kurt ;

Brown, Paul D. ;

Barger, Geoffrey R. ;

Werner-Wasik, Maria ;

Shih, Helen ;

Brachman, David ;

Penas-Prado, Marta ;

Robins, H. Ian ;

Belanger, Karl ;

Schultz, Christopher ;

Hunter, Grant ;

Mehta, Minesh .

NEURO-ONCOLOGY, 2017, 19 (02) :252-258

[10]

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials [J].

Ellingson, Benjamin M. ;

Bendszus, Martin ;

Boxerman, Jerrold ;

Barboriak, Daniel ;

Erickson, Bradley J. ;

Smits, Marion ;

Nelson, Sarah J. ;

Gerstner, Elizabeth ;

Alexander, Brian ;

Goldmacher, Gregory ;

Wick, Wolfgang ;

Vogelbaum, Michael ;

Weller, Michael ;

Galanis, Evanthia ;

Kalpathy-Cramer, Jayashree ;

Shankar, Lalitha ;

Jacobs, Paula ;

Pope, Whitney B. ;

Yang, Dewen ;

Chung, Caroline ;

Knopp, Michael V. ;

Cha, Soonme ;

van den Bent, Martin J. ;

Chang, Susan ;

Al Yung, W. K. ;

Cloughesy, Timothy F. ;

Wen, Patrick Y. ;

Gilbert, Mark R. .

NEURO-ONCOLOGY, 2015, 17 (09) :1188-1198

← 1 2 3 4 →